PT-141 (10 mg Vial) Dosage Protocol

Quickstart Highlights

PT-141 (bremelanotide) is a synthetic cyclic heptapeptide and melanocortin receptor agonist (MC3R/MC4R) derived from Melanotan II^[1]. It was FDA-approved in 2019 for hypoactive sexual desire disorder (HSDD) in premenopausal women^[2]. Unlike PDE5 inhibitors, PT-141 acts centrally to enhance sexual desire by increasing dopamine release in brain reward and arousal regions^[3]. This educational protocol presents on-demand subcutaneous administration using a practical dilution for clear insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.

FDA-approved dose: 1.75 mg (1750 mcg) at least 45 minutes before anticipated activity.

Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and on-demand dosing

On-Demand Protocol (3 mL = ~3.33 mg/mL)

Use Case	Dose (mcg)	Units (per injection) (mL)
Standard (FDA-approved)	1750 mcg (1.75 mg)	53 units (0.53 mL)
Lower Starting Dose	1000 mcg (1.0 mg)	30 units (0.30 mL)
Conservative Start	500 mcg (0.5 mg)	15 units (0.15 mL)

Frequency: Inject subcutaneously at least 45 minutes before anticipated sexual activity^[2]. Maximum: One injection per 24 hours; no more than 8 injections per month^[3]. For doses ≤15 units (≤0.15 mL), consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Alternative Daily Protocol (Exploratory)

Some research protocols have explored once-daily administration for metabolic endpoints^[4]. The following is a conservative titration schedule if daily use is being studied:

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–8	500 mcg	15 units (0.15 mL)
Weeks 9–12	1000 mcg	30 units (0.30 mL)
Weeks 13–16	1500 mcg	45 units (0.45 mL)

Note: Daily protocols are not FDA-approved and require appropriate clinical oversight.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on on-demand use (up to 8 doses/month) or extended daily protocols.

Peptide Vials (PT-141, 10 mg each):

On-demand (8 doses/month at 1.75 mg): 2 vials per month
16-week daily protocol: ~10 vials

Insulin Syringes (U-100):

On-demand (8/month): 8 syringes per month
16-week daily: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.

On-demand (2 vials): 6 mL → 1 × 10 mL bottle
16-week daily (10 vials): 30 mL → 3 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each use.

On-demand (8/month): 16 swabs per month
16-week daily: 224 swabs → recommend 3 × 100-count boxes

View Supplier

Protocol Overview

Concise summary of the on-demand regimen.

Goal: Support sexual desire and arousal through central melanocortin receptor activation^[3].

Schedule: On-demand subcutaneous injection ≥45 minutes before anticipated activity.

Dose: 1.75 mg (1750 mcg) per the FDA-approved regimen^[2].

Limits: Maximum once per 24 hours; no more than 8 doses per month^[3].

Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.

Research Disclaimer

PT-141 (10mg Vial) Dosage Protocol